Phase 2 Malignant Melanoma Clinical Trials
16 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–16 of 16 trials
Recruiting
Phase 2
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Malignant Melanoma
Merck Sharp & Dohme LLC160 enrolled38 locationsNCT06961006
Recruiting
Phase 1Phase 2
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Endometrial CancerGastric (Stomach) CancerNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Beijing Tide Pharmaceutical Co., Ltd266 enrolled3 locationsNCT07371663
Recruiting
Phase 2
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Malignant Melanoma Stage IV
Barbara Malene Fischer20 enrolled2 locationsNCT07215182
Recruiting
Phase 1Phase 2
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Malignant Melanoma
Hadassah Medical Organization50 enrolled1 locationNCT01898039
Recruiting
Phase 1Phase 2
AMT-253 in Patients With Advanced Solid Tumours
Advanced Solid TumorsMalignant Melanoma
Multitude Therapeutics Inc.96 enrolled1 locationNCT06209580
Recruiting
Phase 2
Preoperative Planning With PSMA-PET in Melanoma Surgery Trial
Malignant Melanoma
Royal Marsden NHS Foundation Trust16 enrolled1 locationNCT06560905
Recruiting
Phase 1Phase 2
RAPA-201 Therapy of Solid Tumors
Head and Neck CancerEsophageal Squamous Cell CarcinomaSolid Tumor+6 more
Rapa Therapeutics LLC37 enrolled1 locationNCT05144698
Recruiting
Phase 1Phase 2
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Head and Neck CancerMalignant Melanoma
GeneMedicine Co., Ltd.125 enrolled4 locationsNCT06265025
Recruiting
Phase 2
Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery
Malignant MelanomaSinonasal Melanoma
Eye & ENT Hospital of Fudan University45 enrolled1 locationNCT04879654
Recruiting
Phase 2
Melanoma Metastasized to the Brain and Steroids
Malignant Melanoma
Inge Marie Svane80 enrolled3 locationsNCT03563729
Recruiting
Phase 2
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Malignant Melanoma Stage IV
Sheba Medical Center30 enrolled1 locationNCT03166397
Recruiting
Phase 2
A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
Malignant Melanoma
A.J.M. van den Eertwegh214 enrolled1 locationNCT04126876
Active
Phase 2
A phase I/II study of dendritic cell vaccination with NY-ESO-1 and alpha-galactosylceramide in patients with metastatic melanoma.
Malignant Melanoma
Malaghan Institute of Medical Research46 enrolled1 locationACTRN12612001101875
Completed
Phase 2
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)
Malignant Melanoma
Piramal Enterprises Limited36 enrolled1 locationACTRN12609000815268
Completed
Phase 2
Vitamin D following primary treatment of melanoma at high risk of recurrence
Cutaneous malignant melanoma
Melanoma and Skin Cancer Trial75 enrolled2 locationsACTRN12609000351213
Withdrawn
Phase 2
Phase II Study to Determine Predictive Markers of Response to MDX-010 (BMS-734016)
Unresectable Stage III or IV Malignant Melanoma
Bristol-Myers Squibb Pty Ltd.80 enrolled1 locationACTRN12606000010594